These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2973603)

  • 21. Preliminary experience with ceftazidime monotherapy in perinatal infection.
    Amato M; Schaad UB
    Helv Paediatr Acta; 1987; 42(4):297-303. PubMed ID: 3127359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of combination therapy with aspoxicillin and ceftazidime for severe infections complicating hematological disorders].
    Akasaka K; Nasu K; Horiuchi A; Hasegawa H; Tatsumi N; Nin Y; Kitani T; Taniguchi N; Tagawa S; Mosaoka T
    Jpn J Antibiot; 1990 Sep; 43(9):1614-20. PubMed ID: 2262966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of febrile episodes in neutropenic children by ceftazidime combined with netilmicin. Results of a multicenter study apropos of 88 cases].
    Leverger G; Demeocq F; Harousseau JL; Taboureau O; Vannier JP; Boilletot A; de Lumley L; Boutard P; Olive D; Reinert P
    Pathol Biol (Paris); 1987 May; 35(5):648-51. PubMed ID: 3302878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment of pulmonary infection in cystic fibrosis.
    Webb AK
    Scand J Infect Dis Suppl; 1995; 96():24-7. PubMed ID: 7652499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of ceftazidime and aminoglycoside based regimens as empirical treatment in 1316 cases of suspected sepsis in the newborn. European Society for Paediatric Infectious Diseases--Neonatal Sepsis Study Group.
    de Louvois J; Dagan R; Tessin I
    Eur J Pediatr; 1992 Dec; 151(12):876-84. PubMed ID: 1473540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceftazidime in pediatric infections unsuccessfully treated with other antibiotics: an evaluation of its efficacy and tolerability in compromised host.
    Boner AL; Castellani C; Fostini R; Padovani E
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):333-6. PubMed ID: 2942496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of pyocyanic bacillus superinfections in children with cystic fibrosis using a new cephalosporin: ceftazidime].
    Labbé A; Sablayrolles B; Dechamps C; Sirot J; Marty N
    Ann Pediatr (Paris); 1986 Sep; 33(7):625-8. PubMed ID: 3096185
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical evaluation of ceftazidime in the treatment of neonatal infections].
    Arimasu O; Hashira S; Fujii R
    Jpn J Antibiot; 1986 Aug; 39(8):2077-83. PubMed ID: 3540341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical pharmacology of ceftazidime in childhood].
    Sereni F; Rusconi F; Caccamo M; Boccazzi A; Cambisano W; Padoan R
    G Ital Chemioter; 1984; 31(3):223-7. PubMed ID: 6399037
    [No Abstract]   [Full Text] [Related]  

  • 31. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceftazidime: therapeutic results in various infections and kinetic studies.
    Daikos GK; Kosmidis J; Stathakis C; Giamarellou H; Douzinas E; Kastanakis S; Papathanassiou B
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():331-7. PubMed ID: 19803010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
    Cheng K; Smyth RL; Govan JR; Doherty C; Winstanley C; Denning N; Heaf DP; van Saene H; Hart CA
    Lancet; 1996 Sep; 348(9028):639-42. PubMed ID: 8782753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of the pharmacokinetics of tobramycin administered in a single daily dose or in 3 doses in cystic fibrosis].
    Canis F; Trivier D; Vic P; Ategbo S; Turck D; Husson MO
    Pathol Biol (Paris); 1998 Jun; 46(6):449-51. PubMed ID: 9769880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceftazidime in patients with severe Pseudomonas infections.
    Lechi A; Arosio E; Montesi G; Vaona B; Ghidini O; Parrinello E
    Int J Clin Pharmacol Ther Toxicol; 1986 Mar; 24(3):159-64. PubMed ID: 3516892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Results of several different controlled studies with ceftazidime in the treatment of infections in immunosuppressed patients].
    de Pauw BE
    Infection; 1987; 15 Suppl 4():S168-72. PubMed ID: 3312029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A study on ceftazidime in the perinatal period].
    Takase Z; Miyoshi T; Fujiwara M; Nakayama M; Shirafuji H
    Jpn J Antibiot; 1986 Aug; 39(8):2273-9. PubMed ID: 3540357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefsulodin and ceftazidime, two antipseudomonal cephalosporins.
    Smith BR
    Clin Pharm; 1984; 3(4):373-85. PubMed ID: 6380902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of ceftazidime combined with netilmicin in the treatment of febrile episodes occurring after bone marrow transplantation in children].
    Couturier C; Storme B; Demeocq F; Sirot J; Malpuech G; Allouche G
    Pathol Biol (Paris); 1988 May; 36(5):562-6. PubMed ID: 3043358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ceftazidime as initial therapy for suspected bacterial infections in hospitalized pediatric patients.
    Reed MD; O'Brien CA; Aronoff SC; Klinger JD; Blumer JL
    Antimicrob Agents Chemother; 1984 Sep; 26(3):318-21. PubMed ID: 6391368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.